

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma membrane repair (GO:0001778) | 9.16638561 |
| 2 | skeletal muscle adaptation (GO:0043501) | 9.00606466 |
| 3 | skeletal muscle fiber development (GO:0048741) | 8.61482005 |
| 4 | actin filament-based movement (GO:0030048) | 8.23559996 |
| 5 | myotube cell development (GO:0014904) | 7.30985040 |
| 6 | striated muscle contraction (GO:0006941) | 6.64357156 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.61005451 |
| 8 | sarcomere organization (GO:0045214) | 6.58245481 |
| 9 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.33766288 |
| 10 | skeletal muscle tissue regeneration (GO:0043403) | 6.23796849 |
| 11 | creatine metabolic process (GO:0006600) | 6.04478253 |
| 12 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.87724160 |
| 13 | glycogen catabolic process (GO:0005980) | 5.87434044 |
| 14 | cytidine metabolic process (GO:0046087) | 5.84310028 |
| 15 | cytidine catabolic process (GO:0006216) | 5.84310028 |
| 16 | cytidine deamination (GO:0009972) | 5.84310028 |
| 17 | myofibril assembly (GO:0030239) | 5.83074896 |
| 18 | muscle contraction (GO:0006936) | 5.81989507 |
| 19 | response to muscle activity (GO:0014850) | 5.69801420 |
| 20 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.60888395 |
| 21 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.57675023 |
| 22 | carnitine shuttle (GO:0006853) | 5.51401100 |
| 23 | glucan catabolic process (GO:0009251) | 5.49939199 |
| 24 | regulation of cell communication by electrical coupling (GO:0010649) | 5.46549368 |
| 25 | response to inactivity (GO:0014854) | 5.41496517 |
| 26 | striated muscle atrophy (GO:0014891) | 5.40718098 |
| 27 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.35075013 |
| 28 | muscle fiber development (GO:0048747) | 5.25175931 |
| 29 | muscle system process (GO:0003012) | 5.12944258 |
| 30 | cellular polysaccharide catabolic process (GO:0044247) | 5.08843900 |
| 31 | purine nucleotide salvage (GO:0032261) | 5.03356204 |
| 32 | glucan biosynthetic process (GO:0009250) | 5.01596543 |
| 33 | glycogen biosynthetic process (GO:0005978) | 5.01596543 |
| 34 | striated muscle adaptation (GO:0014888) | 4.88772155 |
| 35 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.87750195 |
| 36 | polysaccharide catabolic process (GO:0000272) | 4.80569775 |
| 37 | actomyosin structure organization (GO:0031032) | 4.68456385 |
| 38 | muscle atrophy (GO:0014889) | 4.66629454 |
| 39 | IMP metabolic process (GO:0046040) | 4.65396726 |
| 40 | fatty acid transmembrane transport (GO:1902001) | 4.60596886 |
| 41 | regulation of actin filament-based movement (GO:1903115) | 4.49731605 |
| 42 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.45450308 |
| 43 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.44743347 |
| 44 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.36061568 |
| 45 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.35496507 |
| 46 | NADH metabolic process (GO:0006734) | 4.29559696 |
| 47 | muscle organ development (GO:0007517) | 4.23935464 |
| 48 | cardiac muscle hypertrophy (GO:0003300) | 4.23382135 |
| 49 | glycogen metabolic process (GO:0005977) | 4.19750523 |
| 50 | muscle structure development (GO:0061061) | 4.19410655 |
| 51 | muscle cell cellular homeostasis (GO:0046716) | 4.18550576 |
| 52 | regulation of coenzyme metabolic process (GO:0051196) | 4.11755119 |
| 53 | regulation of cofactor metabolic process (GO:0051193) | 4.11755119 |
| 54 | cellular glucan metabolic process (GO:0006073) | 4.11362508 |
| 55 | glucan metabolic process (GO:0044042) | 4.11362508 |
| 56 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.09073713 |
| 57 | striated muscle hypertrophy (GO:0014897) | 4.03665492 |
| 58 | carnitine transmembrane transport (GO:1902603) | 4.02657094 |
| 59 | neuronal action potential propagation (GO:0019227) | 4.02209208 |
| 60 | striated muscle cell development (GO:0055002) | 4.02049322 |
| 61 | muscle tissue morphogenesis (GO:0060415) | 4.00923097 |
| 62 | response to activity (GO:0014823) | 4.00843361 |
| 63 | regulation of relaxation of muscle (GO:1901077) | 3.99189296 |
| 64 | muscle organ morphogenesis (GO:0048644) | 3.94943099 |
| 65 | myoblast fusion (GO:0007520) | 3.94020415 |
| 66 | muscle adaptation (GO:0043500) | 3.93824131 |
| 67 | fructose metabolic process (GO:0006000) | 3.92589547 |
| 68 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.86351880 |
| 69 | neuromuscular synaptic transmission (GO:0007274) | 3.85637628 |
| 70 | positive regulation of myotube differentiation (GO:0010831) | 3.84122239 |
| 71 | heart contraction (GO:0060047) | 3.79419937 |
| 72 | heart process (GO:0003015) | 3.79419937 |
| 73 | myotube differentiation (GO:0014902) | 3.78890304 |
| 74 | cardiac muscle contraction (GO:0060048) | 3.78561891 |
| 75 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.77300442 |
| 76 | gluconeogenesis (GO:0006094) | 3.71178777 |
| 77 | tricarboxylic acid cycle (GO:0006099) | 3.70940127 |
| 78 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.68622708 |
| 79 | carnitine transport (GO:0015879) | 3.66255119 |
| 80 | amino-acid betaine transport (GO:0015838) | 3.66255119 |
| 81 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.66207914 |
| 82 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.66207914 |
| 83 | muscle hypertrophy (GO:0014896) | 3.58281913 |
| 84 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.56504561 |
| 85 | syncytium formation (GO:0006949) | 3.55874475 |
| 86 | * skeletal muscle tissue development (GO:0007519) | 3.55258850 |
| 87 | negative regulation of muscle hypertrophy (GO:0014741) | 3.50948213 |
| 88 | regulation of sarcomere organization (GO:0060297) | 3.48651170 |
| 89 | muscle cell development (GO:0055001) | 3.48397811 |
| 90 | IMP biosynthetic process (GO:0006188) | 3.47750508 |
| 91 | cardiac cell development (GO:0055006) | 3.47067437 |
| 92 | 2-oxoglutarate metabolic process (GO:0006103) | 3.46547490 |
| 93 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.44062089 |
| 94 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.44062089 |
| 95 | negative regulation of protein localization to cell surface (GO:2000009) | 3.43251743 |
| 96 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.42416037 |
| 97 | * striated muscle tissue development (GO:0014706) | 3.38514111 |
| 98 | cardiac myofibril assembly (GO:0055003) | 3.35539946 |
| 99 | neuromuscular junction development (GO:0007528) | 3.35113927 |
| 100 | cellular response to dexamethasone stimulus (GO:0071549) | 3.31639961 |
| 101 | hexose biosynthetic process (GO:0019319) | 3.31526259 |
| 102 | negative regulation of muscle contraction (GO:0045932) | 3.30197003 |
| 103 | regulation of muscle system process (GO:0090257) | 3.30076037 |
| 104 | regulation of sulfur metabolic process (GO:0042762) | 3.29319714 |
| 105 | muscle cell fate commitment (GO:0042693) | 3.27849742 |
| 106 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.27185152 |
| 107 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.26588468 |
| 108 | adult heart development (GO:0007512) | 3.23956597 |
| 109 | regulation of myoblast differentiation (GO:0045661) | 3.20596965 |
| 110 | regulation of myotube differentiation (GO:0010830) | 3.18549333 |
| 111 | muscle hypertrophy in response to stress (GO:0003299) | 3.18463121 |
| 112 | regulation of striated muscle contraction (GO:0006942) | 3.17199909 |
| 113 | skeletal muscle cell differentiation (GO:0035914) | 3.17113065 |
| 114 | cardiac muscle cell development (GO:0055013) | 3.17041306 |
| 115 | cellular carbohydrate catabolic process (GO:0044275) | 3.16524834 |
| 116 | positive regulation of myoblast differentiation (GO:0045663) | 3.14468301 |
| 117 | response to dexamethasone (GO:0071548) | 3.08207653 |
| 118 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.07596784 |
| 119 | regulation of membrane repolarization (GO:0060306) | 3.04990658 |
| 120 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.04023543 |
| 121 | actin-myosin filament sliding (GO:0033275) | 13.3362138 |
| 122 | muscle filament sliding (GO:0030049) | 13.3362138 |
| 123 | regulation of skeletal muscle contraction (GO:0014819) | 11.8906454 |
| 124 | skeletal muscle contraction (GO:0003009) | 11.4228201 |
| 125 | actin-mediated cell contraction (GO:0070252) | 10.9658615 |
| 126 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.4374232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.73610357 |
| 2 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 4.02450014 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.91009557 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.32618619 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.31436840 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.96703860 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.75414033 |
| 8 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.75414033 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.71722627 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.65937302 |
| 11 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.55413314 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.29267870 |
| 13 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.20109415 |
| 14 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.18752481 |
| 15 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.07320920 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.06537344 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.00586767 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.91825362 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.91321550 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.88782566 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.84093715 |
| 22 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.74183436 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.73774440 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73353030 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69515214 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.62487307 |
| 27 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.59104416 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.58902951 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58267985 |
| 30 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.57169637 |
| 31 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.53814049 |
| 32 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.50169148 |
| 33 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.49609239 |
| 34 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.49365977 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.47344021 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46578761 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36394371 |
| 38 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34746619 |
| 39 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.33976845 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33601110 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32481606 |
| 42 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.29575982 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28651184 |
| 44 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.27999460 |
| 45 | SA1_27219007_Chip-Seq_Bcells_Human | 1.26582469 |
| 46 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26211849 |
| 47 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.26144918 |
| 48 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.23769735 |
| 49 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.21529631 |
| 50 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18587896 |
| 51 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17764631 |
| 52 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17764631 |
| 53 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16983505 |
| 54 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.16551453 |
| 55 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16004372 |
| 56 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15958449 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13441010 |
| 58 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.12962200 |
| 59 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.12361738 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11942488 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10587854 |
| 62 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09705948 |
| 63 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.09582424 |
| 64 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.08142391 |
| 65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08106042 |
| 66 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.07968007 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07886662 |
| 68 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07362984 |
| 69 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.07124585 |
| 70 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.06797169 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06583027 |
| 72 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06551841 |
| 73 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05931064 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05002392 |
| 75 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03865415 |
| 76 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.03678180 |
| 77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02991249 |
| 78 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02807224 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02754738 |
| 80 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02295196 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02018047 |
| 82 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01966215 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01341660 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01324022 |
| 85 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01258453 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00968118 |
| 87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00968118 |
| 88 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.00698221 |
| 89 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.00441413 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99922625 |
| 91 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99879705 |
| 92 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99873044 |
| 93 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99605170 |
| 94 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98202841 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95594061 |
| 96 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95467617 |
| 97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93873031 |
| 98 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.93845253 |
| 99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93553673 |
| 100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91410829 |
| 101 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91305404 |
| 102 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91217797 |
| 103 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90831227 |
| 104 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90418710 |
| 105 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.89850067 |
| 106 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89677275 |
| 107 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89164683 |
| 108 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88444687 |
| 109 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.87919193 |
| 110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87677250 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87199614 |
| 112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87028187 |
| 113 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86781731 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86353547 |
| 115 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.85869384 |
| 116 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85838352 |
| 117 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85809624 |
| 118 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.84548582 |
| 119 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.84182930 |
| 120 | * GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.84094751 |
| 121 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82774446 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82334631 |
| 123 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81913064 |
| 124 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81062211 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79685099 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79172815 |
| 127 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.77336329 |
| 128 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.77295672 |
| 129 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.77106616 |
| 130 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.76102129 |
| 131 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.76066482 |
| 132 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.75273720 |
| 133 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.74467586 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.71791748 |
| 135 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.69470334 |
| 136 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.69154650 |
| 137 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.68168992 |
| 138 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.67548450 |
| 139 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.67354308 |
| 140 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67148653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.80554043 |
| 2 | MP0000749_muscle_degeneration | 6.46661353 |
| 3 | MP0003646_muscle_fatigue | 6.01340101 |
| 4 | MP0000751_myopathy | 5.97886404 |
| 5 | MP0000747_muscle_weakness | 4.56135629 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.28157908 |
| 7 | MP0000759_abnormal_skeletal_muscle | 3.88666412 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.82235615 |
| 9 | MP0000750_abnormal_muscle_regeneration | 3.63986257 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 3.63117874 |
| 11 | MP0002269_muscular_atrophy | 3.57060644 |
| 12 | MP0005369_muscle_phenotype | 3.55807559 |
| 13 | MP0004087_abnormal_muscle_fiber | 3.50384763 |
| 14 | MP0005451_abnormal_body_composition | 3.05485467 |
| 15 | MP0004130_abnormal_muscle_cell | 3.05452195 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.99108377 |
| 17 | MP0004233_abnormal_muscle_weight | 2.92701400 |
| 18 | MP0000733_abnormal_muscle_development | 2.79575843 |
| 19 | MP0002332_abnormal_exercise_endurance | 2.09167805 |
| 20 | MP0002108_abnormal_muscle_morphology | 2.06482183 |
| 21 | MP0005330_cardiomyopathy | 1.98839871 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.75242492 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.72807855 |
| 24 | MP0004270_analgesia | 1.65982910 |
| 25 | MP0004185_abnormal_adipocyte_glucose | 1.53568635 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.43372932 |
| 27 | MP0002971_abnormal_brown_adipose | 1.39097754 |
| 28 | MP0004484_altered_response_of | 1.36811413 |
| 29 | MP0002972_abnormal_cardiac_muscle | 1.33185043 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.29454838 |
| 31 | MP0005666_abnormal_adipose_tissue | 1.29141520 |
| 32 | MP0010630_abnormal_cardiac_muscle | 1.24612875 |
| 33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15260153 |
| 34 | MP0002234_abnormal_pharynx_morphology | 1.04025823 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.02502659 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.01156786 |
| 37 | MP0005375_adipose_tissue_phenotype | 0.99614425 |
| 38 | MP0002822_catalepsy | 0.98566259 |
| 39 | MP0005266_abnormal_metabolism | 0.97442156 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 0.96161551 |
| 41 | MP0001299_abnormal_eye_distance/ | 0.95971449 |
| 42 | MP0001544_abnormal_cardiovascular_syste | 0.91503667 |
| 43 | MP0005385_cardiovascular_system_phenoty | 0.91503667 |
| 44 | MP0001661_extended_life_span | 0.91250458 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 0.88468933 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 0.88419795 |
| 47 | MP0009250_abnormal_appendicular_skeleto | 0.88325036 |
| 48 | MP0004134_abnormal_chest_morphology | 0.85957341 |
| 49 | MP0003137_abnormal_impulse_conducting | 0.85009428 |
| 50 | MP0004147_increased_porphyrin_level | 0.73814046 |
| 51 | MP0000762_abnormal_tongue_morphology | 0.68170044 |
| 52 | MP0000003_abnormal_adipose_tissue | 0.62148673 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 0.61441751 |
| 54 | MP0010030_abnormal_orbit_morphology | 0.60845967 |
| 55 | MP0003879_abnormal_hair_cell | 0.58040153 |
| 56 | MP0008961_abnormal_basal_metabolism | 0.57005841 |
| 57 | MP0000266_abnormal_heart_morphology | 0.56671615 |
| 58 | MP0004043_abnormal_pH_regulation | 0.56136342 |
| 59 | MP0000372_irregular_coat_pigmentation | 0.55885517 |
| 60 | MP0002896_abnormal_bone_mineralization | 0.55575542 |
| 61 | MP0008775_abnormal_heart_ventricle | 0.54442957 |
| 62 | MP0006138_congestive_heart_failure | 0.52737255 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.52305898 |
| 64 | MP0002127_abnormal_cardiovascular_syste | 0.52107802 |
| 65 | MP0005334_abnormal_fat_pad | 0.51577705 |
| 66 | MP0003959_abnormal_lean_body | 0.48485419 |
| 67 | MP0002114_abnormal_axial_skeleton | 0.46062211 |
| 68 | MP0005452_abnormal_adipose_tissue | 0.45108871 |
| 69 | MP0008569_lethality_at_weaning | 0.44590436 |
| 70 | MP0000343_altered_response_to | 0.43442688 |
| 71 | MP0002089_abnormal_postnatal_growth/wei | 0.42742845 |
| 72 | MP0003045_fibrosis | 0.42522392 |
| 73 | MP0005670_abnormal_white_adipose | 0.40513193 |
| 74 | MP0005275_abnormal_skin_tensile | 0.37681829 |
| 75 | MP0005083_abnormal_biliary_tract | 0.36540797 |
| 76 | MP0001849_ear_inflammation | 0.36473410 |
| 77 | MP0009672_abnormal_birth_weight | 0.36112083 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 0.36016740 |
| 79 | MP0003828_pulmonary_edema | 0.35122542 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.34919627 |
| 81 | MP0003385_abnormal_body_wall | 0.34149948 |
| 82 | MP0003948_abnormal_gas_homeostasis | 0.33573650 |
| 83 | MP0003567_abnormal_fetal_cardiomyocyte | 0.32802892 |
| 84 | MP0002249_abnormal_larynx_morphology | 0.32273570 |
| 85 | MP0004510_myositis | 0.31506365 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.30699743 |
| 87 | MP0002932_abnormal_joint_morphology | 0.30120777 |
| 88 | MP0004085_abnormal_heartbeat | 0.29901041 |
| 89 | MP0003755_abnormal_palate_morphology | 0.29432657 |
| 90 | MP0001943_abnormal_respiration | 0.28800047 |
| 91 | MP0005165_increased_susceptibility_to | 0.28561688 |
| 92 | MP0002128_abnormal_blood_circulation | 0.27359261 |
| 93 | MP0005166_decreased_susceptibility_to | 0.27196421 |
| 94 | MP0004858_abnormal_nervous_system | 0.26871694 |
| 95 | MP0005623_abnormal_meninges_morphology | 0.26117153 |
| 96 | MP0009115_abnormal_fat_cell | 0.25867741 |
| 97 | MP0005535_abnormal_body_temperature | 0.25300394 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.25103610 |
| 99 | MP0002638_abnormal_pupillary_reflex | 0.25057142 |
| 100 | MP0005503_abnormal_tendon_morphology | 0.24215821 |
| 101 | MP0005187_abnormal_penis_morphology | 0.23936925 |
| 102 | MP0005423_abnormal_somatic_nervous | 0.23246596 |
| 103 | MP0004142_abnormal_muscle_tone | 0.23027904 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.21480971 |
| 105 | MP0001243_abnormal_dermal_layer | 0.21428533 |
| 106 | MP0001542_abnormal_bone_strength | 0.21384235 |
| 107 | MP0005332_abnormal_amino_acid | 0.21284961 |
| 108 | MP0004197_abnormal_fetal_growth/weight/ | 0.20998910 |
| 109 | MP0000767_abnormal_smooth_muscle | 0.20804713 |
| 110 | MP0008770_decreased_survivor_rate | 0.20587352 |
| 111 | MP0001346_abnormal_lacrimal_gland | 0.20396484 |
| 112 | MP0002066_abnormal_motor_capabilities/c | 0.20291331 |
| 113 | MP0001440_abnormal_grooming_behavior | 0.20007536 |
| 114 | MP0003279_aneurysm | 0.19596127 |
| 115 | MP0002734_abnormal_mechanical_nocicepti | 0.19376256 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.18862069 |
| 117 | MP0005595_abnormal_vascular_smooth | 0.18127903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 9.99928855 |
| 2 | Type 1 muscle fiber predominance (HP:0003803) | 8.18305517 |
| 3 | Exercise-induced myalgia (HP:0003738) | 7.77790300 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 7.01184606 |
| 5 | Distal arthrogryposis (HP:0005684) | 6.93488670 |
| 6 | Myopathic facies (HP:0002058) | 6.63288414 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.47104572 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 5.82357565 |
| 9 | Round ear (HP:0100830) | 5.67263323 |
| 10 | Ulnar deviation of the wrist (HP:0003049) | 5.45080728 |
| 11 | Difficulty running (HP:0009046) | 5.34518846 |
| 12 | Muscle fiber splitting (HP:0003555) | 5.25249662 |
| 13 | Calcaneovalgus deformity (HP:0001848) | 4.83354684 |
| 14 | EMG: myopathic abnormalities (HP:0003458) | 4.69934489 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 4.64965852 |
| 16 | Absent phalangeal crease (HP:0006109) | 4.53268321 |
| 17 | Myoglobinuria (HP:0002913) | 4.52947225 |
| 18 | Muscle stiffness (HP:0003552) | 4.41632380 |
| 19 | Deformed tarsal bones (HP:0008119) | 4.34790746 |
| 20 | Increased connective tissue (HP:0009025) | 4.28950053 |
| 21 | Abnormality of the calf musculature (HP:0001430) | 4.26726541 |
| 22 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.11133985 |
| 23 | Myotonia (HP:0002486) | 3.83519581 |
| 24 | Rhabdomyolysis (HP:0003201) | 3.82312216 |
| 25 | Abnormal finger flexion creases (HP:0006143) | 3.79900444 |
| 26 | Malignant hyperthermia (HP:0002047) | 3.78406929 |
| 27 | Neck muscle weakness (HP:0000467) | 3.76476943 |
| 28 | Difficulty climbing stairs (HP:0003551) | 3.67656364 |
| 29 | Increased variability in muscle fiber diameter (HP:0003557) | 3.56703297 |
| 30 | Rimmed vacuoles (HP:0003805) | 3.50013542 |
| 31 | Shoulder girdle muscle weakness (HP:0003547) | 3.36404458 |
| 32 | Pelvic girdle muscle weakness (HP:0003749) | 3.36336513 |
| 33 | Frequent falls (HP:0002359) | 3.29563598 |
| 34 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.25306973 |
| 35 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.25306973 |
| 36 | Subaortic stenosis (HP:0001682) | 3.21167239 |
| 37 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.21167239 |
| 38 | Areflexia of lower limbs (HP:0002522) | 3.00953181 |
| 39 | Abnormality of the neuromuscular junction (HP:0003398) | 2.96699213 |
| 40 | Fatigable weakness (HP:0003473) | 2.96699213 |
| 41 | Abnormality of the calcaneus (HP:0008364) | 2.92862057 |
| 42 | Slender build (HP:0001533) | 2.81195612 |
| 43 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.73835292 |
| 44 | Bundle branch block (HP:0011710) | 2.69283612 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 2.65553849 |
| 46 | Fetal akinesia sequence (HP:0001989) | 2.65527173 |
| 47 | Hyperkalemia (HP:0002153) | 2.58429795 |
| 48 | Weak cry (HP:0001612) | 2.54476921 |
| 49 | Amniotic constriction ring (HP:0009775) | 2.53480209 |
| 50 | Abnormality of placental membranes (HP:0011409) | 2.53480209 |
| 51 | Bulbar palsy (HP:0001283) | 2.52357331 |
| 52 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.51819598 |
| 53 | Gowers sign (HP:0003391) | 2.49381477 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.48198221 |
| 55 | Generalized muscle weakness (HP:0003324) | 2.46081658 |
| 56 | Spinal rigidity (HP:0003306) | 2.45958169 |
| 57 | EMG: neuropathic changes (HP:0003445) | 2.44695395 |
| 58 | Distal lower limb muscle weakness (HP:0009053) | 2.42683457 |
| 59 | Sudden death (HP:0001699) | 2.38660692 |
| 60 | Scapular winging (HP:0003691) | 2.38109039 |
| 61 | Proximal amyotrophy (HP:0007126) | 2.36695656 |
| 62 | Limb-girdle muscle weakness (HP:0003325) | 2.36200248 |
| 63 | Muscular dystrophy (HP:0003560) | 2.34421312 |
| 64 | Progressive muscle weakness (HP:0003323) | 2.32246862 |
| 65 | Facial diplegia (HP:0001349) | 2.30689849 |
| 66 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.26966871 |
| 67 | Nonprogressive disorder (HP:0003680) | 2.23762096 |
| 68 | Limb-girdle muscle atrophy (HP:0003797) | 2.20764518 |
| 69 | Paralysis (HP:0003470) | 2.13095900 |
| 70 | Hip contracture (HP:0003273) | 2.12323357 |
| 71 | Hypoplastic ischia (HP:0003175) | 2.03151226 |
| 72 | Muscle fiber inclusion bodies (HP:0100299) | 11.2184758 |
| 73 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.6027963 |
| 74 | Ulnar deviation of finger (HP:0009465) | 1.96793739 |
| 75 | Achilles tendon contracture (HP:0001771) | 1.94619994 |
| 76 | Waddling gait (HP:0002515) | 1.92794659 |
| 77 | Type 2 muscle fiber atrophy (HP:0003554) | 1.91354002 |
| 78 | Lower limb amyotrophy (HP:0007210) | 1.89406497 |
| 79 | Metatarsus adductus (HP:0001840) | 1.85715655 |
| 80 | Aplasia of the musculature (HP:0100854) | 1.85399057 |
| 81 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.80407042 |
| 82 | Abnormality of the ischium (HP:0003174) | 1.76887792 |
| 83 | Abnormality of the Achilles tendon (HP:0005109) | 1.76507600 |
| 84 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.76321717 |
| 85 | Muscle fiber atrophy (HP:0100295) | 1.73431064 |
| 86 | Heart block (HP:0012722) | 1.71776854 |
| 87 | Breech presentation (HP:0001623) | 1.67706997 |
| 88 | Increased density of long bones (HP:0006392) | 1.65291958 |
| 89 | Exercise intolerance (HP:0003546) | 1.62220407 |
| 90 | Abnormal atrioventricular conduction (HP:0005150) | 1.62133541 |
| 91 | Congenital hip dislocation (HP:0001374) | 1.60092828 |
| 92 | Thin ribs (HP:0000883) | 1.56898639 |
| 93 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.56677947 |
| 94 | Short palpebral fissure (HP:0012745) | 1.53014585 |
| 95 | Easy fatigability (HP:0003388) | 1.52596288 |
| 96 | Ventricular arrhythmia (HP:0004308) | 1.52156981 |
| 97 | Tarsal synostosis (HP:0008368) | 1.51239665 |
| 98 | Long clavicles (HP:0000890) | 1.50592856 |
| 99 | Ventricular tachycardia (HP:0004756) | 1.49823063 |
| 100 | Adducted thumb (HP:0001181) | 1.46145021 |
| 101 | Limited hip movement (HP:0008800) | 1.44887641 |
| 102 | Lipoatrophy (HP:0100578) | 1.43707612 |
| 103 | Dilated cardiomyopathy (HP:0001644) | 1.43344774 |
| 104 | Foot dorsiflexor weakness (HP:0009027) | 1.43123635 |
| 105 | Ragged-red muscle fibers (HP:0003200) | 1.41640664 |
| 106 | Pterygium (HP:0001059) | 1.40824283 |
| 107 | Abnormality of the foot musculature (HP:0001436) | 1.39012359 |
| 108 | Popliteal pterygium (HP:0009756) | 1.37119503 |
| 109 | Cholelithiasis (HP:0001081) | 1.36682176 |
| 110 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.35306145 |
| 111 | Synostosis involving bones of the feet (HP:0009140) | 1.35306145 |
| 112 | Stridor (HP:0010307) | 1.34813228 |
| 113 | Akinesia (HP:0002304) | 1.32463425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.20978800 |
| 2 | PHKG1 | 4.70352129 |
| 3 | PHKG2 | 4.70352129 |
| 4 | PIK3CG | 4.14638766 |
| 5 | NME1 | 3.87189271 |
| 6 | MAP2K3 | 2.65412369 |
| 7 | MUSK | 2.11221071 |
| 8 | NEK1 | 2.08394457 |
| 9 | MAP3K7 | 2.03272583 |
| 10 | OBSCN | 10.2190979 |
| 11 | PINK1 | 1.84911570 |
| 12 | PDK4 | 1.80566184 |
| 13 | PDK3 | 1.80566184 |
| 14 | DMPK | 1.78719896 |
| 15 | TRIB3 | 1.68364808 |
| 16 | MAPK12 | 1.51934102 |
| 17 | MAP2K4 | 1.48976351 |
| 18 | BCKDK | 1.35918637 |
| 19 | CCNB1 | 1.35633609 |
| 20 | PDK2 | 1.20695772 |
| 21 | PIK3CA | 1.17403866 |
| 22 | MAP2K6 | 1.12568717 |
| 23 | MARK1 | 0.95921134 |
| 24 | MAP3K3 | 0.87619742 |
| 25 | NEK9 | 0.81895672 |
| 26 | PKN2 | 0.77408059 |
| 27 | ERBB3 | 0.74103428 |
| 28 | AKT2 | 0.71085789 |
| 29 | TAOK2 | 0.70542100 |
| 30 | PRKAA1 | 0.70278437 |
| 31 | MAPKAPK3 | 0.70221908 |
| 32 | PRKAA2 | 0.69077057 |
| 33 | RIPK1 | 0.69017187 |
| 34 | EPHB1 | 0.60506070 |
| 35 | TRPM7 | 0.60453077 |
| 36 | MOS | 0.60424176 |
| 37 | MAPK11 | 0.59664629 |
| 38 | LIMK1 | 0.58895824 |
| 39 | MAP3K13 | 0.57784511 |
| 40 | CAMK2G | 0.53564954 |
| 41 | STK24 | 0.52631776 |
| 42 | MAP3K11 | 0.49157969 |
| 43 | CAMK4 | 0.47814069 |
| 44 | ILK | 0.47396486 |
| 45 | SIK1 | 0.47278411 |
| 46 | TAOK1 | 0.47011708 |
| 47 | ZAK | 0.42683643 |
| 48 | CAMK2B | 0.41389454 |
| 49 | CDK19 | 0.40841889 |
| 50 | MAP3K10 | 0.37111996 |
| 51 | PTK6 | 0.36363268 |
| 52 | FGFR4 | 0.35145167 |
| 53 | CAMK1 | 0.34666622 |
| 54 | EEF2K | 0.34156735 |
| 55 | ROCK1 | 0.33200426 |
| 56 | LATS2 | 0.29933579 |
| 57 | RPS6KB2 | 0.27837134 |
| 58 | SGK1 | 0.27809504 |
| 59 | MAP3K6 | 0.26933322 |
| 60 | LATS1 | 0.26716365 |
| 61 | PRKACB | 0.26070390 |
| 62 | RPS6KB1 | 0.25242548 |
| 63 | PAK6 | 0.24916225 |
| 64 | PRKG1 | 0.24865108 |
| 65 | RPS6KA3 | 0.24569622 |
| 66 | BMX | 0.24332212 |
| 67 | MAP3K5 | 0.24180212 |
| 68 | TBK1 | 0.24153310 |
| 69 | KSR2 | 0.23321147 |
| 70 | SGK2 | 0.23201682 |
| 71 | PKN1 | 0.22916670 |
| 72 | ICK | 0.19834357 |
| 73 | MAP3K1 | 0.19682956 |
| 74 | ARAF | 0.19195447 |
| 75 | MAP2K1 | 0.18721857 |
| 76 | MAPK13 | 0.18607629 |
| 77 | MAPK4 | 0.15887414 |
| 78 | ROCK2 | 0.15825567 |
| 79 | DAPK2 | 0.15642541 |
| 80 | MTOR | 0.15029873 |
| 81 | PDPK1 | 0.15017376 |
| 82 | PRKACA | 0.14601124 |
| 83 | MARK2 | 0.13253752 |
| 84 | PRKD1 | 0.12426910 |
| 85 | MAPK7 | 0.12357847 |
| 86 | FGFR1 | 0.10943176 |
| 87 | DYRK1B | 0.10633791 |
| 88 | LRRK2 | 0.10530683 |
| 89 | CAMK2D | 0.09902019 |
| 90 | PDK1 | 0.09697206 |
| 91 | MARK3 | 0.09087079 |
| 92 | PRPF4B | 0.08844365 |
| 93 | PRKG2 | 0.08049697 |
| 94 | MAPK10 | 0.07860696 |
| 95 | RPS6KL1 | 0.07421548 |
| 96 | RPS6KC1 | 0.07421548 |
| 97 | PDGFRA | 0.07161022 |
| 98 | TIE1 | 0.06958787 |
| 99 | MAP3K4 | 0.06070812 |
| 100 | SGK494 | 0.05727826 |
| 101 | SGK223 | 0.05727826 |
| 102 | DDR2 | 0.04988628 |
| 103 | ZAP70 | 0.04949224 |
| 104 | FER | 0.04915214 |
| 105 | RAF1 | 0.04387419 |
| 106 | KSR1 | 0.04249019 |
| 107 | DAPK3 | 0.04156036 |
| 108 | MAPK8 | 0.04071838 |
| 109 | RPS6KA1 | 0.03995983 |
| 110 | CAMK1G | 0.03410798 |
| 111 | STK11 | 0.03362162 |
| 112 | RPS6KA6 | 0.03274372 |
| 113 | TGFBR2 | 0.02928625 |
| 114 | SGK3 | 0.02576751 |
| 115 | CDK8 | 0.02487669 |
| 116 | EPHA3 | 0.02307494 |
| 117 | GSK3A | 0.02275370 |
| 118 | CSNK1D | 0.02210791 |
| 119 | GSK3B | 0.02153195 |
| 120 | INSRR | 0.01867247 |
| 121 | WNK1 | 0.01434028 |
| 122 | RET | 0.01165724 |
| 123 | MAPK9 | 0.00888230 |
| 124 | PRKACG | 0.00642464 |
| 125 | CAMK2A | 0.00427407 |
| 126 | PTK2B | 0.00313497 |
| 127 | RPS6KA2 | -0.0042875 |
| 128 | CDK6 | -0.0024555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.53440242 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.35568731 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.89423168 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.81458070 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.66761489 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.37348126 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.84747418 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.31593672 |
| 9 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.27559285 |
| 10 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.22877091 |
| 11 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.18897475 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.15563859 |
| 13 | Circadian rhythm_Homo sapiens_hsa04710 | 2.12922396 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.08738599 |
| 15 | Insulin resistance_Homo sapiens_hsa04931 | 2.00804461 |
| 16 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.88378230 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.83224698 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.69371094 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.68240885 |
| 20 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.67834788 |
| 21 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.61815293 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.52615450 |
| 23 | Galactose metabolism_Homo sapiens_hsa00052 | 1.52069090 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49041250 |
| 25 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.48568792 |
| 26 | Tight junction_Homo sapiens_hsa04530 | 1.47948346 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.42152246 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39682621 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.39245681 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.38386863 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36529979 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.29122527 |
| 33 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.27733046 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.22540317 |
| 35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.20618410 |
| 36 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11805685 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11128140 |
| 38 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04096430 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01588267 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00337232 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.98757998 |
| 42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96706290 |
| 43 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.94379172 |
| 44 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.93988921 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89983417 |
| 46 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81778070 |
| 47 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.81403243 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78741469 |
| 49 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78229941 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.77014995 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76714660 |
| 52 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76042277 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75088310 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74808409 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67087325 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67061213 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.66137123 |
| 58 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65106398 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56730884 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54684130 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.54396871 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.53632134 |
| 63 | Insulin secretion_Homo sapiens_hsa04911 | 0.50318625 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.48818010 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48803375 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47293403 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45351789 |
| 68 | Salivary secretion_Homo sapiens_hsa04970 | 0.43713192 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43195519 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43012202 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39486966 |
| 72 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37802837 |
| 73 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.36291930 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35514433 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34882030 |
| 76 | Long-term depression_Homo sapiens_hsa04730 | 0.34069670 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.33791633 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31565352 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.30639193 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.30538062 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30212902 |
| 82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.29780082 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.28511634 |
| 84 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26034968 |
| 85 | Peroxisome_Homo sapiens_hsa04146 | 0.24757988 |
| 86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.24651670 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.23342985 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.22528517 |
| 89 | Purine metabolism_Homo sapiens_hsa00230 | 0.21998651 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.21875368 |
| 91 | Melanogenesis_Homo sapiens_hsa04916 | 0.21016689 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20277501 |
| 93 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.18799930 |
| 94 | Gap junction_Homo sapiens_hsa04540 | 0.17651365 |
| 95 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.17391289 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15360106 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14520584 |
| 98 | Circadian entrainment_Homo sapiens_hsa04713 | 0.14345330 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14327713 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.14025343 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.13549737 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.13322799 |
| 103 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.13277642 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.12088412 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.09011141 |
| 106 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.08797823 |
| 107 | Long-term potentiation_Homo sapiens_hsa04720 | 0.08510024 |
| 108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.08221530 |
| 109 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.07885326 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07423126 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.07258155 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.06780206 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06534009 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.06195712 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.05746911 |
| 116 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.04974283 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.04960950 |
| 118 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.04696275 |
| 119 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.03991455 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.03875310 |

